---
figid: PMC9320820__JCB-123-1053-g005
pmcid: PMC9320820
image_filename: JCB-123-1053-g005.jpg
figure_link: /pmc/articles/PMC9320820/figure/jcb30244-fig-0005/
number: Figure 5
figure_title: ''
caption: Proposed mechanism of WNT/β‐catenin signaling and inhibition in rat articular
  chondrocytes. WNT/β‐catenin agonist LiCl inhibits MMP‐13 and PGE2 production when
  stimulated with IL‐1β, but only protects against the TNF‐α‐stimulated increases
  in PGE2 and not MMP‐13. Inhibiting WNT/β‐catenin signaling using XAV or PKF exacerbated
  the production of MMP‐13 and PGE2 in IL‐1β‐stimulated cultures, but only PGE2 in
  TNF‐α‐stimulated cultures. How miR‐122 and miR‐451 are interacting with the WNT/β‐catenin
  signaling pathway remains to be elucidated. AA, arachidonic acid; IL‐1β, interleukin‐1β;
  LiCl, lithium chloride; MMP‐13, matrix metalloproteinase‐13; PGE2, prostaglandin
  E2; TNF‐α, tumor necrosis factor‐α.
article_title: miR‐122 and the WNT/β‐catenin pathway inhibit effects of both interleukin‐1β
  and tumor necrosis factor‐α in articular chondrocytes in vitro.
citation: Kayla M. Scott, et al. J Cell Biochem. 2022 Jun;123(6):1053-1063.
year: '2022'

doi: 10.1002/jcb.30244
journal_title: Journal of Cellular Biochemistry
journal_nlm_ta: J Cell Biochem
publisher_name: John Wiley and Sons Inc.

keywords:
- chondrocytes
- interleukin‐1β
- miR‐122
- miR‐451
- osteoarthritis
- tumor Necrosis Factor‐α
- WNT/β‐catenin

---
